Title : Phase I and pharmacokinetic trial of weekly oral fluorouracil given with eniluracil and low-dose leucovorin to patients with solid tumors.

Pub. Date : 2000 Dec 1

PMID : 11099325






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Two weeks later, patients began treatment with eniluracil (20 mg) and leucovorin (15 mg) (PO bid on days 1 through 3) and 5-FU (10 to 15 mg/m(2) PO bid on day 2). Leucovorin BH3 interacting domain death agonist Homo sapiens
2 CONCLUSION: The recommended oral dosage of 5-FU (10 mg/m(2) PO bid) given with eniluracil and leucovorin is approximately 115-fold lower than the reference dosage for 24-hour infusional 5-FU. Leucovorin BH3 interacting domain death agonist Homo sapiens